5.1 Glycogen Metabolism & Fatty Acid Synthesis/Beta-Oxidation
Key Takeaways
- Glycogenesis synthesizes glycogen using UDP-glucose; Glycogen Synthase forms alpha-1,4 glycosidic bonds (rate-limiting), while Branching Enzyme creates alpha-1,6 branch points.
- Glycogenolysis breaks down glycogen via Glycogen Phosphorylase (rate-limiting, phosphorolysis yielding G1P), while Debranching Enzyme handles alpha-1,6 branch points.
- Fatty Acid Synthesis occurs in the cytosol of liver cells; Acetyl-CoA Carboxylase (ACC, rate-limiting, requires biotin/ATP) generates malonyl-CoA, and Fatty Acid Synthase (FAS) uses 14 NADPH to yield Palmitate.
- Beta-Oxidation occurs in the mitochondrial matrix; Carnitine Acyltransferase I (CAT-1, rate-limiting, inhibited by malonyl-CoA) shuttles fatty acids, yielding 106 net ATP per Palmitate (16:0).
Introduction to Glycogen Metabolism
Glycogen is a highly branched homopolymer of glucose that functions as the primary rapid-access carbohydrate storage molecule in animal cells. Humans store glucose as glycogen predominantly in two major tissues: skeletal muscle (~400 g) and the liver (~100 g). Although muscle contains a larger absolute quantity of glycogen due to total muscle mass, muscle glycogen is reserved exclusively for endogenous ATP generation during muscle contraction. In contrast, liver glycogen serves as a dynamic glucose reservoir that is broken down and exported into the bloodstream to maintain systemic blood glucose homeostasis during fasting.
Glycogen structure features a linear core of glucose residues joined by $\alpha$-1,4 glycosidic bonds, with branch points introduced approximately every 8 to 12 glucose residues via $\alpha$-1,6 glycosidic bonds. The branched architecture provides two crucial physiological advantages:
- Increased Solubility: Branching creates a compact, spherical macromolecule with high aqueous solubility, preventing osmotic disruption of hepatocytes and myocytes.
- Multiple Non-Reducing Ends: Dynamic enzymatic synthesis and degradation occur exclusively at the non-reducing ends of glycogen chains. Having thousands of non-reducing ends per molecule allows rapid release or storage of glucose units during acute metabolic stress.
Glycogenesis: Glycogen Synthesis Pathway
Glycogenesis is the anabolic pathway that converts free intracellular glucose-6-phosphate (G6P) into glycogen during energy-rich, postprandial states. The pathway proceeds through three sequential enzymatic steps:
1. Isomerization & Activation (UDP-Glucose Pyrophosphorylase)
First, phosphoglucomutase reversibly isomerizes G6P into glucose-1-phosphate (G1P). G1P is subsequently activated by reacting with uridine triphosphate (UTP) to form uridine diphosphate glucose (UDP-glucose), catalyzed by UDP-glucose pyrophosphorylase:
This exergonic activation step is driven forward by the immediate irreversible hydrolysis of inorganic pyrophosphate ($\text{PP}_i$) into $2\text{ P}_i$ by inorganic pyrophosphatase ($\Delta G^{\circ \prime} \approx -19.2\text{ kJ/mol}$).
2. Elongation (Glycogen Synthase)
Glycogen Synthase is the rate-limiting enzyme of glycogenesis. It catalyzes the transfer of the glucosyl moiety from UDP-glucose to the $C_4$ hydroxyl group of a non-reducing terminal glucose residue on an existing glycogen primer, forming a new $\alpha$-1,4 glycosidic bond and releasing UDP:
Note: Glycogen synthase requires a pre-existing glycogen chain or a protein primer named glycogenin, a self-glucosylation enzyme that synthesizes an initial 8-residue glucose primer anchored to its own tyrosine residue.
3. Branching (Branching Enzyme)
Linear $\alpha$-1,4 elongation continues until a chain reaches at least 11 glucose residues in length. At this point, Branching Enzyme (amylo-$\alpha(1,4) \rightarrow \alpha(1,6)$-transglucosidase) cleaves an oligomer of approximately 7 glucose residues from the non-reducing end of the chain and transfers it to the $C_6$ hydroxyl group of an internal glucose residue on the same or an adjacent chain, forming a new $\alpha$-1,6 glycosidic branch point.
Glycogenesis Pathway:
Glucose -> G6P -> G1P + UTP --(UDP-Glucose Pyrophosphorylase)--> UDP-Glucose
|
(Glycogen Synthase)
Forms alpha-1,4 bonds
|
(Branching Enzyme)
Forms alpha-1,6 branches
Glycogenolysis: Glycogen Degradation Pathway
Glycogenolysis is the catabolic mobilization of stored glycogen into G1P and free glucose during fasting, exercise, or hypoglycemia.
1. Phosphorolysis (Glycogen Phosphorylase)
Glycogen Phosphorylase is the rate-limiting enzyme of glycogenolysis. Unlike digestive hydrolases, glycogen phosphorylase uses inorganic phosphate ($\text{P}_i$) rather than water to cleave $\alpha$-1,4 glycosidic bonds from non-reducing ends, releasing glucose-1-phosphate (G1P):
Phosphorolysis preserves cellular energy because the released glucose is already phosphorylated (G1P $\rightarrow$ G6P without consuming ATP). Glycogen phosphorylase requires pyridoxal phosphate (PLP), a cofactor derived from Vitamin $\text{B}_6$, to participate in acid-base catalysis.
2. Debranching Mechanism (Debranching Enzyme)
Glycogen phosphorylase cannot cleave $\alpha$-1,4 bonds within 4 glucose residues of an $\alpha$-1,6 branch point. The resulting steric-hindered structure is called a limit dextrin. Processing limit dextrins requires the bifunctional Debranching Enzyme:
- $4\text{-}\alpha\text{-D-Glucanotransferase}$ Activity: Transfers the outer 3 glucose residues of the 4-residue branch to the non-reducing end of a neighboring main chain, exposing the single glucose attached via an $\alpha$-1,6 linkage.
- $\alpha\text{-1,6-Glucosidase}$ Activity: Hydrolytically cleaves the remaining single $\alpha$-1,6 branch point glucose residue, releasing one free glucose molecule (not G1P!).
AAMC MCAT Trap: ~90% of glucose released during glycogenolysis is G1P (via glycogen phosphorylase phosphorolysis), while ~10% is released as free glucose (via the $\alpha$-1,6-glucosidase activity of debranching enzyme).
3. Fate of G1P in Muscle vs. Liver
G1P is isomerized to G6P by phosphoglucomutase. In the liver, G6P enters the lumen of the endoplasmic reticulum and is converted to free glucose by glucose-6-phosphatase (G6Pase) for export into the bloodstream. In skeletal muscle, G6Pase is completely absent; muscle G6P enters glycolysis directly to fuel muscle contraction.
Reciprocal Hormonal & Allosteric Regulation
Glycogenesis and glycogenolysis are reciprocally regulated by hormonal signaling cascades and allosteric effectors to prevent futile cycling.
| Regulator | Glycogen Phosphorylase (Glycogenolysis) | Glycogen Synthase (Glycogenesis) | Mechanism / Signaling Pathway |
|---|---|---|---|
| Glucagon (Liver) | Activated ($a$ form) | Inhibited ($b$ form) | $G_{\alpha s} \rightarrow \text{AC} \rightarrow \text{cAMP} \rightarrow \text{PKA}$ phosphorylation |
| Epinephrine (Liver & Muscle) | Activated ($a$ form) | Inhibited ($b$ form) | $G_{\alpha s}/G_{\alpha q} \rightarrow \text{PKA/PKC}$ phosphorylation |
| Insulin (Liver & Muscle) | Inhibited ($b$ form) | Activated ($a$ form) | Receptor Tyrosine Kinase $\rightarrow \text{PP1}$ dephosphorylation |
| AMP (Muscle) | Activated | No direct effect | Allosteric indicator of low energy state |
| ATP & G6P (Muscle) | Inhibited | Activated | Allosteric indicators of high energy state |
| Free Glucose (Liver) | Inhibited | No direct effect | Shifts active $a$ form to T-state for inactivation |
Glucagon / Epinephrine Signaling Cascade:
[Hormone] -> GPCR (Gs) -> Adenylate Cyclase -> cAMP ↑ -> PKA Active
|
+-----------------------------------------------+-----------------------------------+
| |
v v
Phosphorylates Phosphorylase Kinase (Active) Phosphorylates Glycogen Synthase (Inactivated)
|
v
Phosphorylates Glycogen Phosphorylase -> Phosphorylase a (ACTIVE)
Fatty Acid Synthesis (Lipogenesis)
Fatty acid synthesis occurs primarily in the cytosol of liver parenchymal cells during energy surplus when carbohydrate intake is abundant.
1. Citrate Shuttle (Export of Acetyl-CoA)
Acetyl-CoA produced in the mitochondrial matrix cannot cross the inner mitochondrial membrane. When mitochondrial ATP levels are high, isocitrate dehydrogenase is inhibited, causing intramitochondrial citrate to accumulate. Citrate is exported via the citrate carrier to the cytosol, where ATP-citrate lyase cleaves it into acetyl-CoA and oxaloacetate (OAA):
Cytosolic OAA is reduced to malate by malic dehydrogenase, and malate is converted to pyruvate by malic enzyme, generating cytosolic NADPH required for fatty acid synthesis.
2. Acetyl-CoA Carboxylase (ACC) — Rate-Limiting Step
Acetyl-CoA Carboxylase (ACC) catalyzes the irreversible carboxylation of acetyl-CoA to malonyl-CoA, consuming one bicarbonate ($\text{HCO}_3^-$) and one ATP:
ACC requires Biotin (Vitamin $\text{B}_7$) as a covalent carrier of $\text{CO}_2$. ACC is allosterically activated by citrate and inhibited by palmitoyl-CoA. Hormonally, insulin dephosphorylates and activates ACC, whereas glucagon and epinephrine phosphorylate and inactivate ACC via PKA.
3. Fatty Acid Synthase (FAS) Multienzyme Complex
Fatty Acid Synthase (FAS) is a homodimeric enzyme complex containing an Acyl Carrier Protein (ACP) with a 4'-phosphopantetheine prosthetic group. Synthesis starts with one acetyl-CoA starter unit and sequentially adds 2-carbon units from malonyl-CoA, releasing $\text{CO}_2$ in each cycle.
Each round of elongation involves 4 repeating steps:
- Condensation: Acetoacetyl-ACP formed (releases $\text{CO}_2$).
- Reduction: $\text{NADPH} \rightarrow \text{NADP}^+$ (hydroxyl formed).
- Dehydration: $\text{H}_2\text{O}$ lost (trans-double bond formed).
- Reduction: $\text{NADPH} \rightarrow \text{NADP}^+$ (saturated acyl-ACP formed).
To synthesize one 16-carbon Palmitate (16:0), 7 cycles are required, consuming 1 Acetyl-CoA, 7 Malonyl-CoA, and 14 NADPH:
Fatty Acid Beta-Oxidation (Lipolysis)
Fatty acid $\beta$-oxidation occurs within the mitochondrial matrix during fasting, starving, or exercise to generate acetyl-CoA, NADH, and $\text{FADH}_2$.
1. Activation & Carnitine Shuttle
Free fatty acids in the cytosol are activated to acyl-CoA by acyl-CoA synthetase at the outer mitochondrial membrane, consuming 2 high-energy phosphate equivalents ($\text{ATP} \rightarrow \text{AMP} + \text{PP}_i$). Long-chain acyl-CoA molecules cannot cross the inner mitochondrial membrane and require the Carnitine Shuttle:
- Carnitine Acyltransferase I (CAT-1 / CPT-1): Located on the outer mitochondrial membrane; rate-limiting enzyme of $\beta$-oxidation. Transfers acyl group from CoA to carnitine, forming acylcarnitine.
- Carnitine-Acylcarnitine Translocase: Transfers acylcarnitine into the matrix while exporting free carnitine.
- Carnitine Acyltransferase II (CAT-2 / CPT-2): Located on the inner mitochondrial membrane matrix side; transfers acyl group back to matrix CoA, regenerating acyl-CoA and free carnitine.
AAMC MCAT Trap: CAT-1 is potently inhibited by Malonyl-CoA (the product of ACC). High malonyl-CoA during fatty acid synthesis prevents newly synthesized fatty acids from immediately entering the mitochondria for degradation.
2. Four Repeating Reactions of Beta-Oxidation
Each round of $\beta$-oxidation cleaves a 2-carbon acetyl-CoA unit from the carboxyl end of acyl-CoA through 4 steps:
- Oxidation: Acyl-CoA Dehydrogenase introduces a trans-$\Delta^2$ double bond, reducing $\text{FAD} \rightarrow \text{FADH}_2$.
- Hydration: Enoyl-CoA Hydratase adds $\text{H}_2\text{O}$ across the double bond to yield L-3-hydroxyacyl-CoA.
- Oxidation: L-3-Hydroxyacyl-CoA Dehydrogenase oxidizes the hydroxyl to a ketone, reducing $\text{NAD}^+ \rightarrow \text{NADH}$.
- Thiolysis: $\beta$-Ketoacyl-CoA Thiolase cleaves the $\beta$-ketoacyl-CoA using CoA-SH, releasing Acetyl-CoA and an acyl-CoA shortened by 2 carbons.
3. Net ATP Calculation for Palmitate (16:0)
Palmitate (16 carbons) undergoes 7 cycles of $\beta$-oxidation:
- Yields: 8 Acetyl-CoA, 7 NADH, and 7 $\text{FADH}_2$.
- 8 Acetyl-CoA $\times 10\text{ ATP}$ per TCA cycle = $80\text{ ATP}$
- 7 NADH $\times 2.5\text{ ATP}$ = $17.5\text{ ATP}$
- 7 $\text{FADH}_2 \times 1.5\text{ ATP}$ = $10.5\text{ ATP}$
- Gross ATP generated = $108\text{ ATP}$
- Minus 2 ATP equivalents consumed during initial activation = 106 Net ATP.
| Feature | Fatty Acid Synthesis | Fatty Acid Beta-Oxidation |
|---|---|---|
| Subcellular Location | Cytosol | Mitochondrial Matrix |
| Rate-Limiting Enzyme | Acetyl-CoA Carboxylase (ACC) | Carnitine Acyltransferase I (CAT-1) |
| Electron Carriers Used | NADPH (consumed) | $\text{FAD}$ & $\text{NAD}^+$ (reduced to $\text{FADH}_2$ & NADH) |
| Key Intermediates / Activator | Citrate (activates ACC), Malonyl-CoA | Malonyl-CoA (inhibits CAT-1) |
| Hormonal Stimulants | Insulin | Glucagon & Epinephrine |
Which enzyme catalyzes the rate-limiting step of fatty acid synthesis and requires biotin as a cofactor?
What is the net yield of ATP generated from the complete oxidation of one molecule of Palmitate (16:0) to carbon dioxide and water, accounting for activation costs?
Elevated intracellular levels of protein kinase A (PKA) activity in response to glucagon binding lead to which pair of regulatory outcomes in liver carbohydrate metabolism?